GLP-1 & wellness peptide prices after the intake quiz

Summary by treatment

Post-questionnaire prices by treatment, recorded October 19–20, 2026

Introductory offers can end after the first shipment. Read the renewal amount and billing interval alongside the first quote.

First-quote and renewal columns show observed competitor quotes; PGP is publisher-configured. Providers counts unique names across both classes. Rates span different terms, quantities and promotions; renewal ranges may cover a different subset. Native-week quotes retain their recorded units. Neither class establishes all-in card charges or medically equivalent doses.

• CSV ↗
• JSON ↗
• Hugging Face dataset (v1.8.2) ↗

What the post-intake quotes showed.

Tirzepatide injection

Tirzepatide injection observed quotes ranged from $145–$339 per labelled plan month; PGP configured prices ranged from $135–$225 per billing month. Together, their overall monthly-equivalent span was $135–$339.

Compare the terms ↗

Semaglutide injection

Semaglutide injection observed quotes ranged from $94–$279 per labelled plan month; PGP configured prices ranged from $99–$175 per billing month. Together, their overall monthly-equivalent span was $94–$279.

Compare the terms ↗

Recorded renewals

20 of the 25 observed quotes with a recorded renewal showed a higher next bill. Renewal totals were not established for 71 of the 96 observed quotes. On a comparable monthly basis, 20 of 23 recorded renewals were higher.

Read first quotes and renewals ↗

Largest total-bill increase · tied

The largest recorded increase in a total bill was $300: Effecty’s 12-month compounded semaglutide quote rose from $1,260 to $1,560 on 12-month renewal. Effecty’s 12-month compounded tirzepatide quote tied this increase. This is a change in the whole term’s bill, not a $300 monthly increase.

See the recorded quote ↗

Where PGP’s configured prices sit in each category

• Tirzepatide injection: PGP configured prices of $135–$225 per billing month overlapped and extended below the observed quote range of $145–$339 per labelled month. View plans ↗
• Semaglutide injection: PGP configured prices of $99–$175 per billing month sat within the observed quote range of $94–$279 per labelled month. View plans ↗
• Tirzepatide sublingual drops: PGP configured prices of $107–$186 per billing month fell below the observed quote range of $246–$254.15 per labelled month. View plans ↗
• NAD+ nasal spray: PGP configured prices of $145–$199 per billing month overlapped and extended above the observed quote range of $111.20–$170 per labelled month. View plans ↗
• PT-141 (bremelanotide): no PGP configured price was collected; observed quote rates ranged from $149 per labelled month. View plans ↗
• Tirzepatide microdosing: PGP configured prices of $115–$205 per billing month sat within the observed quote range of $109–$269 per labelled month. View plans ↗
• Glutathione: no PGP configured price was collected; observed quote rates ranged from $66.40–$239 per labelled month. View plans ↗
• GHK-Cu cream: PGP configured prices of $90–$172 per billing month overlapped and extended below and above the observed quote range of $99–$150 per labelled month. View plans ↗
• Oral tirzepatide tablets; sublingual route unverified: PGP configured prices ranged from $240–$339 per billing month; no observed competitor quote range was established. View plans ↗

Monthly equivalents retain recorded month-labelled terms; native-week plans stay in their original units. Ranges span different terms, doses, quantities and promotions. PGP configured prices and observed competitor quotes are separate evidence classes, not independent observations of the same kind.

What changes after the first month?

Three AgelessRx records show the difference. Each amount below links to its captured quote; the same first-price and renewal labels apply to every provider in the detailed tables.

• AGELESSRX · TIRZEPATIDE MICRODOSING. First month trial $109; Next quoted bill $318 every 2 months. Equivalent to $159 per billing month. See quote & screenshots ↗
• AGELESSRX · TIRZEPATIDE INJECTION. First month quote $279; Next quoted bill $349 every month. See quote & screenshots ↗
• AGELESSRX · GHK-CU CREAM. First month quote $99; Next quoted bill $129 every month. See quote & screenshots ↗

A few examples, with the terms attached.

• PRETTY GIRLS PEPTIDE · SEMAGLUTIDE INJECTION. PGP’s configured one-month plan is $175. Checkout renewal was not independently observed. See PGP plan details ↗
• AGELESSRX · TIRZEPATIDE INJECTION. CTG70 reduced the first selected month to $279. The captured next bill was $349 every month. See quote & screenshots ↗
• GOOD LIFE MEDS · NAD+ NASAL SPRAY. The selected quote showed $111.20 after DW20, versus $139 before the code. Renewal for this promotion was not established. See quote & screenshots ↗

Dated October 2026 records. Selected quotes are not paid receipts; PGP’s offer is publisher-configured. See all eight price findings ↗

Eight prices you can trace.

Open any price below to see the plan term, date and source. Competitor quotes include saved screenshots; PGP prices are supplied from its own plan settings. These examples come from the October 20, 2026 release.

1. Pretty Girls Peptide’s Semaglutide Plan (injection) records a $175 total for the one-month billing interval; checkout renewal was not independently observed.

   See price & source ↗

2. Pretty Girls Peptide’s Tirzepatide Plan (injection) records a $597 total for the quarterly (three-month) billing interval; checkout renewal was not independently observed.

   See price & source ↗

3. Pretty Girls Peptide’s NAD+ Nasal Spray 300 mg/mL plan records a $525 total for the quarterly (three-month) billing interval; checkout renewal was not independently observed.

   See price & source ↗

4. Good Life Meds’ selected one-month-labelled NAD+ nasal spray quote showed a $111.20 total after DW20, compared with $139 before the code; the promotion’s renewal amount was not established.

   See price & source ↗

5. AgelessRx’s selected monthly compounded tirzepatide quote showed $279 initially with the displayed CTG70 promotion and $349 on monthly renewal.

   See price & source ↗

6. Lovely Meds’ selected three-month-labelled tirzepatide injection plan showed a $537 initial total after NEW60, compared with $597 before the code; an exact future renewal total was not itemized.

   See price & source ↗

7. AgelessRx’s selected four-month-labelled Personalized Compounded Semaglutide + Glycine injection plan showed an $856 initial total after TSEMA100 and $956 on four-month renewal.

   See price & source ↗

8. AgelessRx’s selected one-month-labelled PT-141 (bremelanotide) injection quote showed a $149 initial total after PT141INJ50, conditional on prescription, and $199 on monthly renewal; the screen showed $0 due now.

   See price & source ↗

Tirzepatide injection prices

Selected injection quotes retain the provider’s labelled term, any displayed promotion and the stated renewal amount.

Observed quotes were captured on the provider’s own intake on October 19–20, 2026; PGP rows are separately labelled configured prices, not intake observations. Provider names link to each recorded source. Sorted by provider name, then term. Not adjusted for dose or quantity; introductory prices are labelled where shown. Monthly amounts retain source-labelled months or PGP billing intervals; native-week plans are not converted to calendar months.

Semaglutide injection prices

Introductory prices and multi-month totals are shown separately from future renewals when the screen established both.

Observed quotes were captured on the provider’s own intake on October 19–20, 2026; PGP rows are separately labelled configured prices, not intake observations. Provider names link to each recorded source. Sorted by provider name, then term. Not adjusted for dose or quantity; introductory prices are labelled where shown. Monthly amounts retain source-labelled months or PGP billing intervals; native-week plans are not converted to calendar months.

Tirzepatide sublingual drops prices

The observed oral-drop selections and PGP’s configured sublingual drops are retained here. Oral tablets with an unverified route appear separately below.

Observed quotes were captured on the provider’s own intake on October 19–20, 2026; PGP rows are separately labelled configured prices, not intake observations. Provider names link to each recorded source. Sorted by provider name, then term. Not adjusted for dose or quantity; introductory prices are labelled where shown. Monthly amounts retain source-labelled months or PGP billing intervals; native-week plans are not converted to calendar months.

NAD+ nasal spray prices

These are nasal-spray records. They are not compared as equivalent to NAD+ injections, IV treatment or other routes.

Observed quotes were captured on the provider’s own intake on October 19–20, 2026; PGP rows are separately labelled configured prices, not intake observations. Provider names link to each recorded source. Sorted by provider name, then term. Not adjusted for dose or quantity; introductory prices are labelled where shown. Monthly amounts retain source-labelled months or PGP billing intervals; native-week plans are not converted to calendar months.

PT-141 prices

This category currently contains one qualifying observed quote. Other prices are not filled in from advertising or inferred from a different formulation.

Observed quotes were captured on the provider’s own intake on October 19–20, 2026; PGP rows are separately labelled configured prices, not intake observations. Provider names link to each recorded source. Sorted by provider name, then term. Not adjusted for dose or quantity; introductory prices are labelled where shown. Monthly amounts retain source-labelled months or PGP billing intervals; native-week plans are not converted to calendar months.

Tirzepatide microdosing prices

Microdosing is a provider-labelled program category. These plans are not assumed to match standard injection doses, supply or clinical effects.

Observed quotes were captured on the provider’s own intake on October 19–20, 2026; PGP rows are separately labelled configured prices, not intake observations. Provider names link to each recorded source. Sorted by provider name, then term. Not adjusted for dose or quantity; introductory prices are labelled where shown. Monthly amounts retain source-labelled months or PGP billing intervals; native-week plans are not converted to calendar months.

Glutathione prices

The route is shown with each medication. Injection and nasal products remain distinct records, and are not treated as dose-equivalent.

Observed quotes were captured on the provider’s own intake on October 19–20, 2026; PGP rows are separately labelled configured prices, not intake observations. Provider names link to each recorded source. Sorted by provider name, then term. Not adjusted for dose or quantity; introductory prices are labelled where shown. Monthly amounts retain source-labelled months or PGP billing intervals; native-week plans are not converted to calendar months.

GHK-Cu cream prices

Different cream strengths remain visible. Configured billing intervals do not establish the quantity dispensed over the full term.

Observed quotes were captured on the provider’s own intake on October 19–20, 2026; PGP rows are separately labelled configured prices, not intake observations. Provider names link to each recorded source. Sorted by provider name, then term. Not adjusted for dose or quantity; introductory prices are labelled where shown. Monthly amounts retain source-labelled months or PGP billing intervals; native-week plans are not converted to calendar months.

Oral tirzepatide tablets prices

These four PGP configurations are outside the confirmed sublingual-drop category: the tablet’s sublingual route was not established. No observed competitor quote is substituted.

Observed quotes were captured on the provider’s own intake on October 19–20, 2026; PGP rows are separately labelled configured prices, not intake observations. Provider names link to each recorded source. Sorted by provider name, then term. Not adjusted for dose or quantity; introductory prices are labelled where shown. Monthly amounts retain source-labelled months or PGP billing intervals; native-week plans are not converted to calendar months.

Screenshot evidence

All 96 observed quotes have linked images. The release contains 196 main evidence images and 66 supporting images; some document earlier stages, gates or public comparisons rather than a primary quote.

The saved selected-plan record shows the context around the price. Observation IDs connect each row to its quote detail and evidence files. Browse screenshots by quote ↗ · Open original screenshot ↗

Provider interfaces are third-party material retained as evidence. The screenshots are not paid receipts. PGP’s configured offers are supported by their benchmark record rather than independent checkout screenshots.

Methods

What sits behind a monthly headline?

A monthly rate is only one part of a plan. The selected term total, an introductory code and the next renewal can describe different amounts. This study records those amounts as they appeared at the selected-plan stage.

The observed table contains 96 selected quote options from eight providers: AgelessRx, Amble, Arbor, Effecty, Fitish, Good Life Meds, Lovely Meds and ReadyRx. The combined comparison adds 32 owner-configured Pretty Girls Peptide offers. Plans are grouped by treatment and sorted by provider, without a provider ranking.

What do the source labels mean? “Observed quote” means we saved a price shown after the provider’s questionnaire. “PGP configured price” means PGP supplied the price from its own plan settings. These are different evidence classes; PGP is both the study publisher and a provider in the comparison. Open “See price & source” for a readable explanation and the supporting record.

One disclosed fictional scenario

The study case was a 35-year-old woman in California, 5′4″ and 172 lb, with a goal of 145 lb, somewhat active, with no known conditions, medications or allergies and no prior use of the study treatments. The case was not pregnant or breastfeeding. The calculated BMI is approximately 29.5. This was a designed scenario, not a verified average U.S. woman.

The selected-plan stage

Only questions actually presented in each flow were answered. Quotes were recorded after the provider’s presented health questions and individual plan selection. Multiple options could follow one questionnaire. Full medical-intake completion, clinician approval and actual card charges were not established. The collector did not complete final clinical submission, card entry or payment; possible backend processing in consent flows was not independently verified.

Prices, terms and promotions

The exact selected total is retained before division by the source-labelled number of months. Four native-week plans retain their weeks and billing days, with no calendar-month conversion. A PGP configured interval records billing configuration and does not prove dispensed supply, final fees or a future checkout charge. A promotion is only attributed where the quote actually showed it.

A public price is a separate check

The 96 observed quotes include five matching exact public totals, 23 differences under documented term or promotion conditions, 29 public-rate-only references and 39 exact public comparisons not established. The final group is an evidence limit, not proof that a price was hidden. Public reference dates and quote dates remain separate.

Read the complete methods ↗ · Download quote detail ↗ · Public reference records ↗

Reading the summary rates

*First-quote rates divide the selected total by the provider’s labelled plan months and may include an introductory discount. Renewal rates divide the recorded renewal total by its recorded billing months; only quotes with both fields are included. The first-quote and renewal ranges can cover different subsets of providers and plans, so they are not a matched price-change calculation. Open the treatment table to compare a specific plan. The four native-week quotes are excluded. These rates do not establish all-in charges or equivalent doses and quantities. PT-141 and sublingual each have one observed provider; glutathione includes injection and nasal records, and GHK-Cu includes different cream strengths.

What the tables cannot establish.

This is a purposive, dated study of selected brands and forms. It does not establish market-wide coverage, medically equivalent dosing, treatment suitability or a cheapest provider for every patient. A missing quote does not prove that a product is unavailable.

• Wisp: no qualifying primary quote is included; lower-stage and public references remain secondary.
• Lovely Meds microdosing: a dedicated microdose selection remained unresolved, so a standard injection quote was not duplicated into that category.
• Oral route: three Fitish oral observations remain secondary because their route evidence conflicts. PGP’s oral tablets stay outside confirmed sublingual drops.
• Availability and formulation: a California research case does not establish availability for every plan. State coverage, dosing, quantity and assigned pharmacy remain unverified where the record does not establish them.

Provider names identify the sources reviewed. Their inclusion does not imply affiliation with or endorsement of this study.

Version and corrections

Dataset v1.8.2 · October 20, 2026. The combined view includes 96 observed competitor quotes and 32 PGP configurations, preserving both evidence labels. This article draft renders those existing records without changing a price, plan term, source date, source URL or observation ID.

Prices can change after the recorded date. Corrections to the dataset require a new release and changelog entry; this page does not promise an active refresh schedule. Read the release history ↗.

Sources

PGP’s original compiled data and original writing are available under CC BY 4.0. Provider screenshots, logos and copied source material retain their third-party rights.

Pretty Girls Peptide (2026). GLP-1 and Wellness Peptide Pricing: What 9 Brands Charge After the Intake Quiz — Incl. NAD+, PT-141, Glutathione, GHK-Cu & Microdosing. October 2026 snapshot, version 1.8.2. https://huggingface.co/datasets/prettygirlspeptide/telehealth-glp1-pricing/tree/v1.8.2

Additional Details

Description

96 competitor quotes captured after brands’ intake questionnaires at the selected-plan stage, rather than advertised list prices, plus 32 separately labelled PGP configured prices.

Published

October 2026

Updated

October 2026 · Dataset v1.8.2